Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.8430
Nov 03 • 4:00 PM ET Dollar change-0.0371 Percentage change(-4.22%)
Aftermarket Close
0.8381
Aftermarket • 4:15 PM ET Dollar change-0.0049 Percentage change(-0.58%)
Nov 02, 8:55 AMStereotaxis reports first-in-human success for Robocath coronary robotic system with 100% PCI success and no device-related events
Index
RUT
Market Cap
84.47M
Enterprise Value
84.38M
Income
-23.59M
Sales
30.07M
Book/sh
0.13
Cash/sh
0.10
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
131
IPO
Aug 12, 2004
P/E
-
Forward P/E
-
PEG
-
P/S
2.81
P/B
6.74
P/C
8.05
P/FCF
-
EV/EBITDA
-
EV/Sales
2.81
Quick Ratio
0.94
Current Ratio
1.41
Debt/Eq
0.30
LT Debt/Eq
0.26
Option/Short
Yes / Yes
EPS (ttm)
-0.24
EPS next Y
-0.15
EPS next Q
-0.05
EPS this Y
17.33%
EPS next Y
27.42%
EPS next 5Y
-
EPS past 3/5Y
0.82% -17.98%
Sales past 3/5Y
4.78% 3.99%
EPS Y/Y TTM
13.55%
Sales Y/Y TTM
-5.47%
EPS Q/Q
-1.49%
Sales Q/Q
-12.82%
Insider Own
23.21%
Insider Trans
0.00%
Inst Own
43.00%
Inst Trans
-2.34%
ROA
-46.14%
ROE
-184.27%
ROIC
-101.65%
Gross Margin
55.57%
Oper. Margin
-65.23%
Profit Margin
-78.45%
SMA20
-16.40%
SMA50
-29.56%
SMA200
-50.14%
Trades
Shs Outstand
97.93M
Shs Float
76.94M
52W High
2.93 -71.23%
52W Low
0.81 4.06%
Volatility
8.47% 5.99%
ATR (14)
0.07
RSI (14)
22.76
Beta
1.39
Rel Volume
2.74
Avg Volume
591.36K
Volume
1,619,212
Perf Week
-18.16%
Perf Month
-28.56%
Perf Quarter
-39.35%
Perf Half Y
-56.09%
Perf YTD
-63.35%
Perf Year
-69.68%
Perf 3Y
-49.52%
Perf 5Y
-86.72%
Perf 10Y
38.20%
Prev Close
0.88
Price
0.84
Change %
-4.22%
Consensus
Strong Buy
Avg. Price Target
$3.00
Implied Upside
+255.9%
Analysts10incl. previous ratings
Rating Distribution10 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 16, 2025Initiated
CCitizens JMP
Mkt Outperform$4+374.5%
Jan 10, 2024Initiated
RROTH MKM
Buy$5+493.1%
Jul 12, 2022Initiated
AAegis Capital
Buy$6+611.7%
Jun 23, 2022Initiated
RILY logoRB. Riley Securities
Buy$6+611.7%
Jan 05, 2022Initiated
LLoop Capital
Buy$13+1,442.1%
Jan 05, 2022Initiated
CCraig Hallum
Buy$11+1,204.9%
May 26, 2021Initiated
PPiper Sandler
Overweight$9+967.6%
Sep 08, 2020Initiated
NNorthland Capital
Outperform$9.50+1,026.9%
Apr 09, 2020Initiated
CCowen
Outperform$6+611.7%
Apr 07, 2020Initiated
LLake Street
Buy$5+493.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Isaac Paul JDirectorNov 14 '25Buy2.2420,00044,8002,786,557Nov 18 03:22 PM
Isaac Paul JDirectorNov 17 '25Buy2.1810,00021,80097,299Nov 18 03:22 PM
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
C.F.A.Dr. David Leo Fischel C.A.I.A.
Chief Financial OfficerMs. Kimberly R. Peery CPA
Vice President of OperationsMr. Keith Galloway
General Counsel & SecretaryMs. Patricia S. Williams Esq.